A quantum generative model for in silico clinical trials using scarce training datasets

Olatz Sanz Larrarte, Reza Dastbasteh, Roberto Sanchez-Navarro +7

In silico methods have emerged as a strategy to complement clinical trials. These are particularly relevant for rare or heterogeneous diseases for which traditional methods are cos…